Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

BACKGROUND: Perioperative chemotherapy and surgery are a standard of care for patients with resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma. However, the prognosis remains poor for this population. The FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) regimen is consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Dos Santos, Mélanie, Lequesne, Justine, Leconte, Alexandra, Corbinais, Stéphane, Parzy, Aurélie, Guilloit, Jean-Marc, Varatharajah, Sharmini, Brachet, Pierre-Emmanuel, Dorbeau, Marine, Vaur, Dominique, Weiswald, Louis-Bastien, Poulain, Laurent, Le Gallic, Corentin, Castera-Tellier, Marie, Galais, Marie-Pierre, Clarisse, Bénédicte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097175/
https://www.ncbi.nlm.nih.gov/pubmed/35549674
http://dx.doi.org/10.1186/s12885-022-09623-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097175/
https://www.ncbi.nlm.nih.gov/pubmed/35549674
http://dx.doi.org/10.1186/s12885-022-09623-z

Ejemplares similares